Brattleboro Rats as the Model of Blood Hyperviscosity Syndrome for Testing Substances with Hemorheological Activity

Verfasser / Beitragende:
[M. Plotnikov, A. Vasil'ev, O. Aliev, L. Zibareva]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 159/5(2015-09-01), 689-691
Format:
Artikel (online)
ID: 605536341
LEADER caa a22 4500
001 605536341
003 CHVBK
005 20210128100852.0
007 cr unu---uuuuu
008 210128e20150901xx s 000 0 eng
024 7 0 |a 10.1007/s10517-015-3048-9  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10517-015-3048-9 
245 0 0 |a Brattleboro Rats as the Model of Blood Hyperviscosity Syndrome for Testing Substances with Hemorheological Activity  |h [Elektronische Daten]  |c [M. Plotnikov, A. Vasil'ev, O. Aliev, L. Zibareva] 
520 3 |a Hyperviscosity syndrome was described in Brattleboro rats. The aim of this study was to investigate the possibility of Brattleboro rats using, as a test system for the study of agents with hemorheological activity. Under conditions of this model of high blood viscosity syndrome in Brattleboro rats, Lychnis chalcedonica L. extract (150 mg/kg) administered intragastrically for 10 days exhibited hemorheological activity by modulating macro- (plasma viscosity, fibrinogen concentration) and microrheological (erythrocyte aggregation and deformability parameters. Hence, Brattleboro rats are an adequate model of hyperviscosity syndrome that can be used for search and testing of substances with hemorheological activity. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a hereditary hypothalamic diabetes insipidus  |2 nationallicence 
690 7 |a Brattleboro rats  |2 nationallicence 
690 7 |a Lychnis chalcedonica extract  |2 nationallicence 
690 7 |a high blood viscosity syndrome  |2 nationallicence 
690 7 |a erythrocyte aggregation and deformability  |2 nationallicence 
700 1 |a Plotnikov  |D M.  |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia  |4 aut 
700 1 |a Vasil'ev  |D A.  |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia  |4 aut 
700 1 |a Aliev  |D O.  |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia  |4 aut 
700 1 |a Zibareva  |D L.  |u National Research Tomsk State University, Tomsk, Russia  |4 aut 
773 0 |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/5(2015-09-01), 689-691  |x 0007-4888  |q 159:5<689  |1 2015  |2 159  |o 10517 
856 4 0 |u https://doi.org/10.1007/s10517-015-3048-9  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10517-015-3048-9  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Plotnikov  |D M.  |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Vasil'ev  |D A.  |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Aliev  |D O.  |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Zibareva  |D L.  |u National Research Tomsk State University, Tomsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/5(2015-09-01), 689-691  |x 0007-4888  |q 159:5<689  |1 2015  |2 159  |o 10517